Axillary staging in post-neoadjuvant chemotherapy breast cancer patients: prognostic analysis and validation of axillary nodal metrics and comparison of the pathological node staging versus the lymph node ratio systems in a 169-case series.

Safavi A, Mohammadzadeh N, Kaviani A, Dadashi A, Dadashi A

Open source

DOI
10.1186/s12885-026-15564-8
Published
2026 Jan 30
Container
BMC cancer
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12885-026-15564-8,
  title = {Axillary staging in post-neoadjuvant chemotherapy breast cancer patients: prognostic analysis and validation of axillary nodal metrics and comparison of the pathological node staging versus the lymph node ratio systems in a 169-case series.},
  author = {Safavi A and Mohammadzadeh N and Kaviani A and Dadashi A and Dadashi A},
  year = {2026},
  journal = {BMC cancer},
  doi = {10.1186/s12885-026-15564-8},
  url = {https://doi.org/10.1186/s12885-026-15564-8}
}

RIS

TY  - JOUR
TI  - Axillary staging in post-neoadjuvant chemotherapy breast cancer patients: prognostic analysis and validation of axillary nodal metrics and comparison of the pathological node staging versus the lymph node ratio systems in a 169-case series.
AU  - Safavi A
AU  - Mohammadzadeh N
AU  - Kaviani A
AU  - Dadashi A
AU  - Dadashi A
PY  - 2026
JO  - BMC cancer
DO  - 10.1186/s12885-026-15564-8
UR  - https://doi.org/10.1186/s12885-026-15564-8
ER  - 

APA

A, S., N, M., A, K., A, D., & A, D. (2026). Axillary staging in post-neoadjuvant chemotherapy breast cancer patients: prognostic analysis and validation of axillary nodal metrics and comparison of the pathological node staging versus the lymph node ratio systems in a 169-case series.. BMC cancer. https://doi.org/10.1186/s12885-026-15564-8

Source records